RFG Advisory’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

RFG Advisory’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-986	Closed	-$281K	–	687
2023 Q2	$281K	Buy	+986	New	+$274K	0.01%	543

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

RFG Advisory's SWAV Position: Q3 2023 in Review

RFG Advisory sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 986 shares — an estimated $281K sold.

RFG Advisory first reported a position in SWAV in Q2 2023 and held it in 1 quarter. The position peaked at $281K in Q2 2023. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

RFG Advisory reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
RFG Advisory sold 986 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $281K.
RFG Advisory first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
RFG Advisory's Shockwave Medical, Inc. Common Stock position peaked at $281K in Q2 2023.
412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on RFG Advisory's 13F filing for Q3 2023, filed 16 Oct 2023.